蜜芽传媒

Steve Young is the first person in the UK to take part in a clinical trial to test a new treatment for preventing skin cancer from returning.

The world's first personalised mRNA cancer jab for melanoma - which also has the potential to stop lung, bladder and kidney cancer - is being tested at the University College Hospital in London.

The jab is designed to trigger the immune system so it can fight back against the patient's specific type of cancer and tumour.

The 52 year old music teacher from Stevenage had a melanoma growth - which is considered high risk 鈥� surgically removed from his scalp.

Steve said the mole-like bump on his head grew significantly in the last few years but when he found out it was melanoma it was a 鈥渉uge shock, totally unexpected鈥�.

鈥淚t was just ignored for years. And really the message is: you just can鈥檛 ignore these things. I鈥檝e been incredibly lucky. The scans came back clear which meat I was eligible for the trial.鈥�

Speaking to 5 Live Breakfast鈥檚 Rachel Burden, Steve said he feels like he鈥檚 been given a 鈥渟econd innings鈥� and that he鈥檚 鈥渞eally loving life at the moment.鈥�

鈥淒oing the trial, if one thing, it鈥檚 making me feel like I鈥檓 doing something. I鈥檓 not just sitting around waiting for a scan to say I鈥檓 clear for another three months. I feel like I鈥檓 fighting it head on. And hopefully this is going to go on to be a success and change the lives of millions of people.鈥�

This clip was originally from 5 Live Breakfast on 26th April 2024.

Show less